Group cognitive remediation therapy for chronic schizophrenia: A randomized controlled trial

Neuroscience Letters

Volumn 626, Issue , 2016, Pages 106-111

  Tan, Shuping ^a,b   Zou, Yizhuang ^b   Wykes, Til ^c   Reeder, Clare ^c   Zhu, Xiaolin ^b   Yang, Fude ^b   Zhao, Yanli ^b   Tan, Yunlong ^b   Fan, Fengmei ^b   Zhou, Dongfeng ^a  

^a PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^b BEIJING HUILONGGUAN HOSPITAL   (China)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cognitive deficits; Cognitive remediation therapy; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CHINA; COGNITION; COGNITIVE REMEDIATION THERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROUP THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SOCIAL INTERACTION; SOCIAL STATUS; TREATMENT OUTCOME; DANCE THERAPY; MIDDLE AGED; MUSIC THERAPY; PSYCHOLOGY;

ADULT; COGNITIVE REMEDIATION; DANCE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSIC THERAPY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 84971294372     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.08.036     Document Type: Article

References (39)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th ed, American Psychiatric Association, Washington, DC (1994).
2. Bark N., Revheim N., Huq F., Khalderov V., Ganz Z.W., Medalia A. The impact of cognitive remediation on psychiatric symptoms of schizophrenia. Schizophr. Res. 2003, 63:229-235.
3. Bowie C.R., Depp C., McGrath J.A., Wolyniec P., Mausbach B.T., Thornquist M.H., Luke J., Patterson T.L., Harvey P.D., Pulver A.E. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am. J. Psychiatry 2010, 167:1116-1124.
4. Cervellione K.L., Burdick K.E., Cottone J.G., Rhinewine J.P., Kumra S. Neurocognitive deficits in adolescents with schizophrenia: longitudinal stability and predictive utility for short-term functional outcome. J. Am. Acad. Child Adolesc. Psychiatry 2007, 46:867-878.
5. Delahunty A., Morice R. Rehabilitation of frontal/executive impairments in schizophrenia. Aust. N. Z. J. Psychiatry 1996, 30:760-767.
6. Dingemans A.E., Danner U.N., Donker J.M., Aardoom J.J., van Meer F., Tobias K., van Elburg A.A., van Furth E.F. The effectiveness of cognitive remediation therapy in patients with a severe or enduring eating disorder: a randomized controlled trial. Psychother. Psychosom. 2014, 83:29-36.
7. Egeland B., Rice J., Penny S. Inter-scorer reliability on the bender gestalt test and the revised visual retention test. Am. J. Ment. Defic. 1967, 72:96-99.
8. Fett A.K., Viechtbauer W., Dominguez M.D., Penn D.L., van Os J., Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci. Biobehav. Rev. 2011, 35:573-588.
9. Fisher M., Holland C., Merzenich M.M., Vinogradov S. Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am. J. Psychiatry. 2009, 166:805-811.
10. Franck N., Duboc C., Sundby C., Amado I., Wykes T., Demily C., Launay C., Le R.V., Bloch P., Willard D., Todd A., Petitjean F., Foullu S., Briant P., Grillon M.L., Deppen P., Verdoux H., Bralet M.C., Januel D., Riche B., Roy P., Vianin P. Specific vs general cognitive remediation for executive functioning in schizophrenia: a multicenter randomized trial. Schizophr. Res. 2013, S0920-S9964. LID-S0920-9964(13)155-2[pii]LID. 10.1016/j.schres.2013.03.009.
11. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia. Am. J. Psychiatry 1996, 153:321-330.
12. Hodge M.A., Siciliano D., Withey P., Moss B., Moore G., Judd G., Shores E.A., Harris A. A randomized controlled trial of cognitive remediation in schizophrenia. Schizophr. Bull. 2010, 36:419-427.
13. Hogarty G.E., Flesher S., Ulrich R., Carter M., Greenwald D., Pogue-Geile M., Kechavan M., Cooley S., DiBarry A.L., Garrett A., Parepally H., Zoretich R. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Arch. Gen. Psychiatry 2004, 61:866-876.
14. Honigfeld G., Gillis R.D., Klett C.J. NOSIE-30: a treatment-sensitive ward behavior scale. Psychol. Rep. 1966, 19:180-182.
15. Keefe R.S., Bilder R.M., Davis S.M., Harvey P.D., Palmer B.W., Gold J.M., Meltzer H.Y., Green M.F., Capuano G., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Davis C.E., Hsiao J.K., Lieberman J.A. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch. Gen. Psychiatry 2007, 64:633-647.
16. Keefe R.S., Bilder R.M., Harvey P.D., Davis S.M., Palmer B.W., Gold J.M., Meltzer H.Y., Green M.F., Miller D.D., Canive J.M., Adler L.W., Manschreck T.C., Swartz M., Rosenheck R., Perkins D.O., Walker T.M., Stroup T.S., McEvoy J.P., Lieberman J.A. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 2006, 31:2033-2046.
17. Kwok T.C., Bai X., Li J.C., Ho F.K., Lee T.M. Effectiveness of cognitive training in Chinese older people with subjective cognitive complaints: a randomized placebo-controlled trial. Int. J. Geriatr. Psychiatry 2013, 28:208-215.
18. Li Y. Application of NOSIE in the study of neuroleptic treatment. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1987, 20:325-327.
19. McGurk S.R., Mueser K.T., Feldman K., Wolfe R., Pascaris A. Cognitive training for supported employment: 2-3 year outcomes of a randomized controlled trial. Am. J. Psychiatry 2007, 164:437-441.
20. McGurk S.R., Twamley E.W., Sitzer D.I., McHugo G.J., Mueser K.T. A meta-analysis of cognitive remediation in schizophrenia. Am. J. Psychiatry 2007, 164:1791-1802.
21. Medalia A., Choi J. Cognitive remediation in schizophrenia. Neuropsychol. Rev. 2009, 19:353-364.
22. Patel A., Knapp M., Romeo R., Reeder C., Matthiasson P., Everitt B., Wykes T. Cognitive remediation therapy in schizophrenia: cost-effectiveness analysis. Schizophr. Res. 2010, 120:217-224.
23. Penades R., Catalan R., Salamero M., Boget T., Puig O., Guarch J., Gasto C. Cognitive remediation therapy for outpatients with chronic schizophrenia: a controlled and randomized study. Schizophr. Res. 2006, 87:323-331.
24. Penades R., Pujol N., Catalan R., Massana G., Rametti G., Garcia-Rizo C., Bargallo N., Gasto C., Bernardo M., Junque C. Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study. Biol. Psychiatry 2013, 73:1015-1023.
25. Phillips M.R., Zhang J., Shi Q., Song Z., Ding Z., Pang S., Li X., Zhang Y., Wang Z. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet 2009, 373:2041-2053.
26. Piskulic D., Barbato M., Liu L., Addington J. Pilot study of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis. Psychiatry Res. 2015, 225:93-98.
27. Reeder C., Newton E., Frangou S., Wykes T. Which executive skills should we target to affect social functioning and symptom change? A study of a cognitive remediation therapy program. Schizophr. Bull. 2004, 30:87-100.
28. Reeder C., Smedley N., Butt K., Bogner D., Wykes T. Cognitive predictors of social functioning improvements following cognitive remediation for schizophrenia. Schizophr. Bull. 2006, 32(Suppl. 1):S123-S131.
29. Sergi M.J., Rassovsky Y., Widmark C., Reist C., Erhart S., Braff D.L., Marder S.R., Green M.F. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr. Res. 2007, 90:316-324.
30. Velligan D.I., Kern R.S., Gold J.M. Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies. Schizophr. Bull. 2006, 32:474-485.
31. Woodward N.D., Purdon S.E., Meltzer H.Y., Zald D.H. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int. J. Neuropsychopharmacol. 2005, 8:457-472.
32. Wykes T., Huddy V. Cognitive remediation for schizophrenia: it is even more complicated. Curr. Opin. Psychiatry 2009, 22:161-167.
33. Wykes T., Huddy V., Cellard C., McGurk S.R., Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am. J. Psychiatry 2011, 168:472-485.
34. Wykes T., Newton E., Landau S., Rice C., Thompson N., Frangou S. Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophr. Res. 2007, 94:221-230.
35. Wykes T., Reeder C., Landau S., Everitt B., Knapp M., Patel A., Romeo R. Cognitive remediation therapy in schizophrenia: randomised controlled trial. Br. J. Psychiatry 2007, 190:421-427.
36. Wykes T., Reeder C., Williams C., Corner J., Rice C., Everitt B. Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophr. Res. 2003, 61:163-174.
37. Wykes T., Steel C., Everitt B., Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr. Bull. 2008, 34:523-537.
38. Wykes T. van der Gaag M, Is it time to develop a new cognitive therapy for psychosis-cognitive remediation therapy (CRT). Clin. Psychol. Rev. 2001, 21:1227-1256.
39. Yanlin H., MingYuan Z. The Chinese norm and factors analysis of PANSS. Chin. J. Clin. Psychol. 2000, 82:65-69.